Oncology and Hematology
A section of Children (ISSN 2227-9067).
Section Information
The Hematology and Oncology Section accepts articles related to the diagnosis and treatment of benign hematologic conditions, childhood and adolescent cancers, and hematopoietic stem cell transplantation for benign and malignant conditions. Articles can focus on therapy, supportive care, long-term outcomes/survivorship, epidemiology and disease prevention, and the economic impact of these diseases (both on the patient and the health care system). Clinical trials and observational studies (cohort studies, case-control studies) are preferred, but systematic reviews/meta-analyses are also welcome as long as they are methodologically rigorous. Case reports will only be considered if they report on a novel finding with important clinical implications.
- Childhood cancer
- Benign hematology
- Hematopoietic stem cell transplant
- Adolescents
- Survivorship/late effects
- Health economics
- Health services research
- Clinical trials
- Solid tumors
- Brain tumors
- Leukemia and lymphoma
- Thrombosis and hemostasis
- Hemoglobinopathies
- Bone marrow failure syndromes
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Pediatric Neuro-Oncology (Deadline: 30 September 2021)
- Current Status of Cancer Research in Adolescents—Problems of Children with Cancer (Deadline: 30 September 2021)
- Surgical Management for Children with Primary Liver Tumors (Deadline: 31 October 2021)
- Clinic Research on Kawasaki Disease in Children (Deadline: 31 October 2021)
- Total Pain Management in Children with Cancer (Deadline: 1 November 2021)
- Palliative Care for Childhood Cancer (Deadline: 15 November 2021)
- Cardio-Oncology in Children (Deadline: 20 December 2021)
- Solid Tumors in Children: Advances and Challenges (Deadline: 31 December 2021)